Literature DB >> 21382441

Morphine sensitization increases the extracellular level of glutamate in CA1 of rat hippocampus via μ-opioid receptor.

Maryam Farahmandfar1, Seyed Morteza Karimian, Mohammad-Reza Zarrindast, Mehdi Kadivar, Hossein Afrouzi, Nasser Naghdi.   

Abstract

Repeated administration of abuse drugs such as morphine elicits a progressive enhancement of drug-induced behavioral responses, a phenomenon termed behavioral sensitization. These changes in behavior may reflect plastic changes requiring regulation of glutamatergic system in the brain. In this study, we investigated the effect of morphine sensitization on extracellular glutamate concentration in the hippocampus, a brain region rich in glutamatergic neurons. Sensitization was induced by subcutaneous (s.c.) injection of morphine, once daily for 3 days followed by 5 days free of the opioid treatment. The results showed that extracellular glutamate concentration in the CA1 was decreased following administration of morphine in non-sensitized rats. However, morphine-induced behavioral sensitization significantly increased the extracellular glutamate concentration in this area. The enhancement of glutamate in morphine sensitized rats was prevented by administration of naloxone 30 min before each of three daily doses of morphine. These results suggest an adaptation of the glutamatergic neuronal transmission in the hippocampus after morphine sensitization and it is postulated that opioid receptors may play an important role in this effect.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21382441     DOI: 10.1016/j.neulet.2011.02.074

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Agmatine Prevents Adaptation of the Hippocampal Glutamate System in Chronic Morphine-Treated Rats.

Authors:  Xiao-Fei Wang; Tai-Yun Zhao; Rui-Bin Su; Ning Wu; Jin Li
Journal:  Neurosci Bull       Date:  2016-05-09       Impact factor: 5.203

2.  In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.

Authors:  Prabhat Singh; Bhupesh Sharma; Surbhi Gupta; B M Sharma
Journal:  Psychopharmacology (Berl)       Date:  2014-07-26       Impact factor: 4.530

3.  Effects of ceftriaxone on hydrocodone seeking behavior and glial glutamate transporters in P rats.

Authors:  Fahad S Alshehri; Alqassem Y Hakami; Yusuf S Althobaiti; Youssef Sari
Journal:  Behav Brain Res       Date:  2018-03-28       Impact factor: 3.332

4.  HIV-1 Tat and Morphine Differentially Disrupt Pyramidal Cell Structure and Function and Spatial Learning in Hippocampal Area CA1: Continuous versus Interrupted Morphine Exposure.

Authors:  William D Marks; Jason J Paris; Aaron J Barbour; Jean Moon; Valerie J Carpenter; Virginia D McLane; Arianna R S Lark; Sara R Nass; Jingli Zhang; Viktor Yarotskyy; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  eNeuro       Date:  2021-05-24

5.  Blockade of Glutamate Receptors within the Prelimbic Cortex Attenuate Concentration of Excitatory Amino Acids in the Morphine Self-administration in Rats.

Authors:  Fateme Aboutalebi; Hojjatallah Alaei; Shahrbanoo Oryan
Journal:  Adv Biomed Res       Date:  2018-08-29

Review 6.  The Mechanisms Involved in Morphine Addiction: An Overview.

Authors:  Joanna Listos; Małgorzata Łupina; Sylwia Talarek; Antonina Mazur; Jolanta Orzelska-Górka; Jolanta Kotlińska
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

7.  Microinjection of WIN55,212-2 as A Cannabinoid Agonist into The Basolateral Amygdala Induces Sensitization to Morphine in Rats.

Authors:  Marzieh Molaei; Mohammad-Hossein Sanati; Jalal Zaringhalam; Abbas Haghparast
Journal:  Basic Clin Neurosci       Date:  2014-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.